has_role organic heterocyclic compound antineoplastic agent carboxamide nilotinib 0 529.18379 529.526 NCIt:C48375 pubmed:19652056 Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide AMN 107 pubmed:39009709 pubmed:39739907 cas:641571-10-0 pubmed:35333006 lincs.smallmolecule:LSM-1099 drugbank:DB04868 CHEBI:52172 pubmed:18922118 pdb-ccd:NIL pubmed:18956997 pubmed:27194024 drugcentral:1932 pubmed:39459541 pubmed:19493708 SNOMEDCT:428468009 pubmed:19527930 pubmed:19449194 InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37) 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide pubmed:39903581 pubmed:18549348 pubmed:39887138 pubmed:17720881 pubmed:17611564 pubmed:18191450 pubmed:39267544 pubmed:18318563 nilotinibum pubmed:17068153 pubmed:39634983 pubmed:19427995 pubmed:17958915 C28H22F3N7O pubmed:18326784 chebi_ontology pubmed:19519355 kegg.drug:D08953 pubmed:17987222 wikipedia.en:Nilotinib pubmed:16775235 MESH:C079909 pubmed:17090651 SNOMEDCT:427941004 pubmed:19188713 nilotinib AMN107 HHZIURLSWUIHRB-UHFFFAOYSA-N